OptiNose Inc
NASDAQ:OPTN

Watchlist Manager
OptiNose Inc Logo
OptiNose Inc
NASDAQ:OPTN
Watchlist
Price: 9.6 USD -1.13% Market Closed
Market Cap: 97.2m USD

Net Margin
OptiNose Inc

-27.5%
Current
-73%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-27.5%
=
Net Income
-21.5m
/
Revenue
78.2m

Net Margin Across Competitors

Country Company Market Cap Net
Margin
US
OptiNose Inc
NASDAQ:OPTN
96.6m USD
-28%
US
Eli Lilly and Co
NYSE:LLY
1T USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
499.6B USD
27%
CH
Roche Holding AG
SIX:ROG
262.5B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
212B GBP
16%
CH
Novartis AG
SIX:NOVN
211.3B CHF
26%
US
Merck & Co Inc
NYSE:MRK
265.6B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.5T DKK
33%
IE
Endo International PLC
LSE:0Y5F
212.8B USD
-126%
US
Pfizer Inc
NYSE:PFE
142.7B USD
16%
No Stocks Found

OptiNose Inc
Glance View

Market Cap
96.6m USD
Industry
Pharmaceuticals

OptiNose, Inc. operates as a pharmaceutical company. The company is headquartered in Yardley, Pennsylvania and currently employs 189 full-time employees. The company went IPO on 2017-10-13. The firm's first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 micrograms (mcg), is a therapeutic utilizing the Company's Exhalation Delivery System (EDS), which delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps. The Onzetra Xsail is a sumatriptan nasal powder and sells in the United States, Canada and Mexico.

OPTN Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-27.5%
=
Net Income
-21.5m
/
Revenue
78.2m
What is the Net Margin of OptiNose Inc?

Based on OptiNose Inc's most recent financial statements, the company has Net Margin of -27.5%.

Back to Top